Suppr超能文献

[智利成年人中α脂蛋白血症降低和升高的机制]

[Mechanisms of hypo and hyper alphalipoproteinemia in Chilean adults].

作者信息

Cuevas Ada, Alvarez Verónica, Acosta Ana María, Altayó Marcela, Montero Joaquín, Rigotti Attilio

机构信息

Departamento de Nutrición, Diabetes y Metabolismo, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.

出版信息

Rev Med Chil. 2004 Apr;132(4):421-8. doi: 10.4067/s0034-98872004000400003.

Abstract

BACKGROUND

High density lipoprotein (HDL) cholesterol is inversely associated to atherosclerotic cardiovascular risk. Disturbances in HDL cholesterol plasma levels are frequent in the Chilean population, however the pathophysiological mechanisms are unknown.

AIM

To evaluate the mechanisms involved in the hypo and hyper alfalipoproteinemias in Chilean subjects.

MATERIALS AND METHODS

Twenty three subjects with hyperalphalipoproteinemia and 12 with hypoalphalipoproteinemia, paired with control subjects (col-HDL between 35 and 55 mg/dl) were studied. We measured plasma lipids, subfractions and sizing of HDL particles and enzymatic activity of cholesteryl ester transfer protein (CETP), lecithtin: cholesterol acyltransferase (LCAT), lipoprotein lipase (LPL) and hepatic lipase (LH).

RESULTS

Subjects with hyperalphalipoproteinemia showed significantly higher levels of total HDL-cholesterol (70 +/- 2 vs 44 +/- 1 mg/dl), HDL 2 (30 +/- 3 vs 5 +/- 1 mg/dl), Apo A I (175 +/- 3 vs 146 +/- 4 mg/dl), lower HL activity (23.7 +/- 0.8 vs 32.4 +/- 1.8 mmol/h/l) and HDL particles of greater size, compared to their controls. Subjects with hypoalphalipoproteinemia, showed significantly lower levels of total HDL-cholesterol (26 +/- 1 vs 48 +/- 2 mg/dl), HDL 3 (21 +/- 1 vs 40 +/- 2 mg/dl), Apo A I (107 +/- 5 vs 145 +/- 7 mg/dl), lower LCAT activity (18.6 +/- 1.9 vs 26.2 +/- 1.6 nmol/h/ml) and smaller HDL particles, compared to their controls.

CONCLUSION

Changes in hepatic lipase and lecithin cholesterol acyltransferase activities may explain the hyper and hypo alphalipoproteinemia respectively, in Chilean subjects.

摘要

背景

高密度脂蛋白(HDL)胆固醇与动脉粥样硬化性心血管风险呈负相关。智利人群中HDL胆固醇血浆水平紊乱较为常见,但其病理生理机制尚不清楚。

目的

评估智利受试者中高和低α脂蛋白血症所涉及的机制。

材料与方法

研究了23例高α脂蛋白血症患者和12例低α脂蛋白血症患者,并与对照受试者(HDL胆固醇水平在35至55mg/dl之间)配对。我们测量了血浆脂质、HDL颗粒的亚组分和大小,以及胆固醇酯转移蛋白(CETP)、卵磷脂胆固醇酰基转移酶(LCAT)、脂蛋白脂肪酶(LPL)和肝脂肪酶(HL)的酶活性。

结果

与对照相比,高α脂蛋白血症患者的总HDL胆固醇水平(70±2 vs 44±1mg/dl)、HDL 2(30±3 vs 5±1mg/dl)、载脂蛋白A I(175±3 vs 146±4mg/dl)显著更高,HL活性更低(23.7±0.8 vs 32.4±1.8mmol/h/l),且HDL颗粒更大。与对照相比,低α脂蛋白血症患者的总HDL胆固醇水平(26±1 vs 48±2mg/dl)、HDL 3(21±1 vs 40±2mg/dl)、载脂蛋白A I(107±5 vs 145±7mg/dl)显著更低,LCAT活性更低(18.6±1.9 vs 26.2±1.6nmol/h/ml),且HDL颗粒更小。

结论

肝脂肪酶和卵磷脂胆固醇酰基转移酶活性的变化可能分别解释了智利受试者中的高和低α脂蛋白血症。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验